Impact of COVID-19 on Patients Receiving Chemotherapy for Gynecological Cancer
November 2021
in “
World Family Medicine Journal /Middle East Journal of Family Medicine
”
Studysummary In this study, 9% of gynecological cancer patients undergoing chemotherapy at a Saudi Arabian hospital contracted COVID-19, and patients with recurrent disease showed higher COVID-19 incidence and mortality.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mejfm.com →